Ankylosing Spondylitis

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate the Efficacy and Safety of Upadacitinib in Adult Subjects with Ankylosing Spondylitis

Study Information


Ankylosing Spondylitis

Phase III

Conquest Research needs volunteers for an ankylosing spondylitis trial evaluating a medication designed for the treatment of ankylosing spondylitis. You may qualify if you:

  • Are at least 18 years of age

  • Have a clinical diagnosis of ankylosing spondylitis

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.

Sign Up For A Study

    What To Expect


    Conquest Research is partnering with physician practices throughout Central Florida to raise awareness and offer clinical research opportunities to those in need.

    A mature medical doctor smiling as some of his colleagues stand in the background

    Register For A Study!